{"entity":{"type":"insider","cik":"0001352455","url":"/insider/0001352455","json_url":"/insider/0001352455.json","name":"Wasman Jane","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":212,"n_filings":43,"first":"2006-11-08","last":"2025-06-02","span_basis":"filed_date"},"name_variants":[{"name":"Wasman Jane","source":"filing","n_filings":43,"first_seen":"2006-11-08","last_seen":"2025-06-02"}],"transactions":[{"id":5128767,"accession":"0001104659-25-055495","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-055495","line_url":"/filing/0001104659-25-055495#line-1","is_derivative":false,"issuer_cik":"0001352455","issuer_name":"SELLAS Life Sciences Group, Inc.","issuer_ticker":"SLS","issuer_name_source":null,"issuer_url":"/issuer/0001352455","owner_cik":"0001352455","owner_name":"Wasman Jane","owner_display_name":"Wasman Jane","owner_url":"/insider/0001352455","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.69,"price_display":"1.69","price_state":"stated","total_value":33800.0,"total_display":"33,800.00","total_whole":"33,800","shares_owned_after":30400.0,"shares_owned_after_display":"30,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-30","filed_date":"2025-06-02","scope":"insider"},{"id":7873371,"accession":"0001209191-19-058939","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-058939","line_url":"/filing/0001209191-19-058939#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352455","owner_name":"Wasman Jane","owner_display_name":"Wasman Jane","owner_url":"/insider/0001352455","role":"Officer (President, Intl and GC)","role_mark":"O","role_mark_label":"Officer (President, Intl and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Intl and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2227.0,"shares_display":"2,227","price_per_share":1.5953,"price_display":"1.60","price_state":"stated","total_value":3552.7331,"total_display":"3,552.73","total_whole":"3,553","shares_owned_after":117420.0,"shares_owned_after_display":"117,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-02","filed_date":"2019-12-04","scope":"insider"},{"id":5966798,"accession":"0001209191-18-061119","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-061119","line_url":"/filing/0001209191-18-061119#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352455","owner_name":"Wasman Jane","owner_display_name":"Wasman Jane","owner_url":"/insider/0001352455","role":"Officer (President, Intl and GC)","role_mark":"O","role_mark_label":"Officer (President, Intl and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Intl and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3067.0,"shares_display":"3,067","price_per_share":20.5241,"price_display":"20.52","price_state":"stated","total_value":62947.4147,"total_display":"62,947.41","total_whole":"62,947","shares_owned_after":105287.0,"shares_owned_after_display":"105,287","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-03","filed_date":"2018-12-06","scope":"insider"},{"id":6447834,"accession":"0001209191-18-004824","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-004824","line_url":"/filing/0001209191-18-004824","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352455","owner_name":"Wasman Jane","owner_display_name":"Wasman Jane","owner_url":"/insider/0001352455","role":"Officer (President, Intl and GC)","role_mark":"O","role_mark_label":"Officer (President, Intl and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Intl and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34520.0,"shares_display":"34,520","price_per_share":27.587464252607184,"price_display":"27.59","price_state":"stated","total_value":952319.266,"total_display":"952,319.27","total_whole":"952,319","shares_owned_after":102460.0,"shares_owned_after_display":"102,460","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-19","filed_date":"2018-01-23","scope":"insider","n_lines":2},{"id":4424021,"accession":"0001209191-17-063699","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-063699","line_url":"/filing/0001209191-17-063699#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352455","owner_name":"Wasman Jane","owner_display_name":"Wasman Jane","owner_url":"/insider/0001352455","role":"Officer (President, Intl and GC)","role_mark":"O","role_mark_label":"Officer (President, Intl and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Intl and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4564.0,"shares_display":"4,564","price_per_share":20.522,"price_display":"20.52","price_state":"stated","total_value":93662.408,"total_display":"93,662.41","total_whole":"93,662","shares_owned_after":102110.0,"shares_owned_after_display":"102,110","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-01","filed_date":"2017-12-05","scope":"insider"},{"id":4971574,"accession":"0001209191-17-009976","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-009976","line_url":"/filing/0001209191-17-009976#line-2","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352455","owner_name":"Wasman Jane","owner_display_name":"Wasman Jane","owner_url":"/insider/0001352455","role":"Officer (President, Intl and GC)","role_mark":"O","role_mark_label":"Officer (President, Intl and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Intl and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":54536.0,"shares_display":"54,536","price_per_share":22.3012,"price_display":"22.30","price_state":"stated","total_value":1216218.2432,"total_display":"1,216,218.24","total_whole":"1,216,218","shares_owned_after":101674.0,"shares_owned_after_display":"101,674","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-09","filed_date":"2017-02-13","scope":"insider"},{"id":3139968,"accession":"0001209191-16-153415","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-153415","line_url":"/filing/0001209191-16-153415","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352455","owner_name":"Wasman Jane","owner_display_name":"Wasman Jane","owner_url":"/insider/0001352455","role":"Officer (President, Intl and GC)","role_mark":"O","role_mark_label":"Officer (President, Intl and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Intl and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3347.0,"shares_display":"3,347","price_per_share":20.73500065730505,"price_display":"20.74","price_state":"stated","total_value":69400.0472,"total_display":"69,400.05","total_whole":"69,400","shares_owned_after":101774.0,"shares_owned_after_display":"101,774","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-01","filed_date":"2016-12-05","scope":"insider","n_lines":2},{"id":2211776,"accession":"0001209191-16-144914","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-144914","line_url":"/filing/0001209191-16-144914#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352455","owner_name":"Wasman Jane","owner_display_name":"Wasman Jane","owner_url":"/insider/0001352455","role":"Officer (President, Intl and GC)","role_mark":"O","role_mark_label":"Officer (President, Intl and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Intl and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3750.0,"shares_display":"3,750","price_per_share":20.7805,"price_display":"20.78","price_state":"stated","total_value":77926.875,"total_display":"77,926.88","total_whole":"77,927","shares_owned_after":105021.0,"shares_owned_after_display":"105,021","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-03","filed_date":"2016-10-05","scope":"insider"},{"id":3321094,"accession":"0001209191-16-142858","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-142858","line_url":"/filing/0001209191-16-142858#line-2","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352455","owner_name":"Wasman Jane","owner_display_name":"Wasman Jane","owner_url":"/insider/0001352455","role":"Officer (President, Intl and GC)","role_mark":"O","role_mark_label":"Officer (President, Intl and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Intl and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":27.3206,"price_display":"27.32","price_state":"stated","total_value":13660.3,"total_display":"13,660.30","total_whole":"13,660","shares_owned_after":108771.0,"shares_owned_after_display":"108,771","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-23","filed_date":"2016-09-27","scope":"insider"},{"id":8382198,"accession":"0001209191-15-087015","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-087015","line_url":"/filing/0001209191-15-087015#line-2","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352455","owner_name":"Wasman Jane","owner_display_name":"Wasman Jane","owner_url":"/insider/0001352455","role":"Officer (President, Intl and GC)","role_mark":"O","role_mark_label":"Officer (President, Intl and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Intl and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10751.0,"shares_display":"10,751","price_per_share":43.1025,"price_display":"43.10","price_state":"stated","total_value":463394.9775,"total_display":"463,394.98","total_whole":"463,395","shares_owned_after":100124.0,"shares_owned_after_display":"100,124","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-23","filed_date":"2015-12-28","scope":"insider"},{"id":8794381,"accession":"0001209191-15-086952","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-086952","line_url":"/filing/0001209191-15-086952","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352455","owner_name":"Wasman Jane","owner_display_name":"Wasman Jane","owner_url":"/insider/0001352455","role":"Officer (President, Intl and GC)","role_mark":"O","role_mark_label":"Officer (President, Intl and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Intl and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13797.0,"shares_display":"13,797","price_per_share":42.43185978835979,"price_display":"42.43","price_state":"stated","total_value":585432.3695,"total_display":"585,432.37","total_whole":"585,432","shares_owned_after":100124.0,"shares_owned_after_display":"100,124","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-22","filed_date":"2015-12-24","scope":"insider","n_lines":2},{"id":8190855,"accession":"0001209191-15-086531","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-086531","line_url":"/filing/0001209191-15-086531#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352455","owner_name":"Wasman Jane","owner_display_name":"Wasman Jane","owner_url":"/insider/0001352455","role":"Officer (President, Intl and GC)","role_mark":"O","role_mark_label":"Officer (President, Intl and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Intl and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":817.0,"shares_display":"817","price_per_share":42.0,"price_display":"42.00","price_state":"stated","total_value":34314.0,"total_display":"34,314.00","total_whole":"34,314","shares_owned_after":108579.0,"shares_owned_after_display":"108,579","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-21","filed_date":"2015-12-22","scope":"insider"},{"id":8775321,"accession":"0001209191-15-086368","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-086368","line_url":"/filing/0001209191-15-086368#line-2","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352455","owner_name":"Wasman Jane","owner_display_name":"Wasman Jane","owner_url":"/insider/0001352455","role":"Officer (President, Intl and GC)","role_mark":"O","role_mark_label":"Officer (President, Intl and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Intl and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3277.0,"shares_display":"3,277","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":131080.0,"total_display":"131,080.00","total_whole":"131,080","shares_owned_after":109396.0,"shares_owned_after_display":"109,396","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-17","filed_date":"2015-12-21","scope":"insider"},{"id":8311278,"accession":"0001209191-15-083243","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-083243","line_url":"/filing/0001209191-15-083243#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352455","owner_name":"Wasman Jane","owner_display_name":"Wasman Jane","owner_url":"/insider/0001352455","role":"Officer (President, Intl and GC)","role_mark":"O","role_mark_label":"Officer (President, Intl and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Intl and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5523.0,"shares_display":"5,523","price_per_share":38.0761,"price_display":"38.08","price_state":"stated","total_value":210294.3003,"total_display":"210,294.30","total_whole":"210,294","shares_owned_after":109396.0,"shares_owned_after_display":"109,396","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-01","filed_date":"2015-12-03","scope":"insider"},{"id":8419331,"accession":"0001209191-15-074443","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-074443","line_url":"/filing/0001209191-15-074443","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352455","owner_name":"Wasman Jane","owner_display_name":"Wasman Jane","owner_url":"/insider/0001352455","role":"Officer (President, Intl and GC)","role_mark":"O","role_mark_label":"Officer (President, Intl and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Intl and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3750.0,"shares_display":"3,750","price_per_share":31.7524196,"price_display":"31.75","price_state":"stated","total_value":119071.5735,"total_display":"119,071.57","total_whole":"119,072","shares_owned_after":98097.0,"shares_owned_after_display":"98,097","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-05","filed_date":"2015-10-06","scope":"insider","n_lines":2},{"id":6206726,"accession":"0001209191-14-072920","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-072920","line_url":"/filing/0001209191-14-072920#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352455","owner_name":"Wasman Jane","owner_display_name":"Wasman Jane","owner_url":"/insider/0001352455","role":"Officer (President, Intl and GC)","role_mark":"O","role_mark_label":"Officer (President, Intl and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Intl and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6956.0,"shares_display":"6,956","price_per_share":35.5766,"price_display":"35.58","price_state":"stated","total_value":247470.8296,"total_display":"247,470.83","total_whole":"247,471","shares_owned_after":94578.0,"shares_owned_after_display":"94,578","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-01","filed_date":"2014-12-03","scope":"insider"},{"id":6953089,"accession":"0001209191-14-066631","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-066631","line_url":"/filing/0001209191-14-066631#line-2","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352455","owner_name":"Wasman Jane","owner_display_name":"Wasman Jane","owner_url":"/insider/0001352455","role":"Officer (President, Intl and GC)","role_mark":"O","role_mark_label":"Officer (President, Intl and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Intl and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14923.0,"shares_display":"14,923","price_per_share":34.8421,"price_display":"34.84","price_state":"stated","total_value":519948.6583,"total_display":"519,948.66","total_whole":"519,949","shares_owned_after":101534.0,"shares_owned_after_display":"101,534","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-03","filed_date":"2014-11-05","scope":"insider"},{"id":6847806,"accession":"0001209191-14-062336","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-062336","line_url":"/filing/0001209191-14-062336#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352455","owner_name":"Wasman Jane","owner_display_name":"Wasman Jane","owner_url":"/insider/0001352455","role":"Officer (President, Intl and GC)","role_mark":"O","role_mark_label":"Officer (President, Intl and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Intl and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3750.0,"shares_display":"3,750","price_per_share":34.1288,"price_display":"34.13","price_state":"stated","total_value":127983.0,"total_display":"127,983.00","total_whole":"127,983","shares_owned_after":101534.0,"shares_owned_after_display":"101,534","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-03","filed_date":"2014-10-07","scope":"insider"},{"id":6652496,"accession":"0001209191-14-059967","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-059967","line_url":"/filing/0001209191-14-059967#line-2","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352455","owner_name":"Wasman Jane","owner_display_name":"Wasman Jane","owner_url":"/insider/0001352455","role":"Officer (President, Intl and GC)","role_mark":"O","role_mark_label":"Officer (President, Intl and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Intl and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14923.0,"shares_display":"14,923","price_per_share":36.0,"price_display":"36.00","price_state":"stated","total_value":537228.0,"total_display":"537,228.00","total_whole":"537,228","shares_owned_after":105284.0,"shares_owned_after_display":"105,284","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-24","filed_date":"2014-09-26","scope":"insider"},{"id":6913518,"accession":"0001209191-14-054908","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-054908","line_url":"/filing/0001209191-14-054908#line-2","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352455","owner_name":"Wasman Jane","owner_display_name":"Wasman Jane","owner_url":"/insider/0001352455","role":"Officer (President, Intl and GC)","role_mark":"O","role_mark_label":"Officer (President, Intl and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Intl and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14923.0,"shares_display":"14,923","price_per_share":33.0,"price_display":"33.00","price_state":"stated","total_value":492459.0,"total_display":"492,459.00","total_whole":"492,459","shares_owned_after":105284.0,"shares_owned_after_display":"105,284","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-27","filed_date":"2014-08-29","scope":"insider"},{"id":5309122,"accession":"0001209191-13-055281","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-055281","line_url":"/filing/0001209191-13-055281#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352455","owner_name":"Wasman Jane","owner_display_name":"Wasman Jane","owner_url":"/insider/0001352455","role":"Officer (President, Intl and GC)","role_mark":"O","role_mark_label":"Officer (President, Intl and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Intl and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8425.0,"shares_display":"8,425","price_per_share":33.5186,"price_display":"33.52","price_state":"stated","total_value":282394.205,"total_display":"282,394.20","total_whole":"282,394","shares_owned_after":97034.0,"shares_owned_after_display":"97,034","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-02","filed_date":"2013-12-04","scope":"insider"},{"id":5512177,"accession":"0001209191-13-047575","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-047575","line_url":"/filing/0001209191-13-047575#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352455","owner_name":"Wasman Jane","owner_display_name":"Wasman Jane","owner_url":"/insider/0001352455","role":"Officer (President, Intl and GC)","role_mark":"O","role_mark_label":"Officer (President, Intl and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Intl and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3750.0,"shares_display":"3,750","price_per_share":35.7357,"price_display":"35.74","price_state":"stated","total_value":134008.875,"total_display":"134,008.88","total_whole":"134,009","shares_owned_after":105459.0,"shares_owned_after_display":"105,459","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-03","filed_date":"2013-10-07","scope":"insider"},{"id":3193589,"accession":"0001209191-12-055901","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-055901","line_url":"/filing/0001209191-12-055901#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352455","owner_name":"Wasman Jane","owner_display_name":"Wasman Jane","owner_url":"/insider/0001352455","role":"Officer (President, Intl and GC)","role_mark":"O","role_mark_label":"Officer (President, Intl and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Intl and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7019.0,"shares_display":"7,019","price_per_share":24.2012,"price_display":"24.20","price_state":"stated","total_value":169868.2228,"total_display":"169,868.22","total_whole":"169,868","shares_owned_after":97951.0,"shares_owned_after_display":"97,951","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-12-03","filed_date":"2012-12-05","scope":"insider"},{"id":9056232,"accession":"0001209191-11-059460","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-059460","line_url":"/filing/0001209191-11-059460#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352455","owner_name":"Wasman Jane","owner_display_name":"Wasman Jane","owner_url":"/insider/0001352455","role":"Officer (Exec VP, General Counsel & Sec)","role_mark":"O","role_mark_label":"Officer (Exec VP, General Counsel & Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec VP, General Counsel & Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7344.0,"shares_display":"7,344","price_per_share":22.92,"price_display":"22.92","price_state":"stated","total_value":168324.48,"total_display":"168,324.48","total_whole":"168,324","shares_owned_after":57570.0,"shares_owned_after_display":"57,570","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-01","filed_date":"2011-12-05","scope":"insider"},{"id":7368725,"accession":"0001209191-10-058333","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-10-058333","line_url":"/filing/0001209191-10-058333","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352455","owner_name":"Wasman Jane","owner_display_name":"Wasman Jane","owner_url":"/insider/0001352455","role":"Officer (Exec VP, General Counsel & Sec)","role_mark":"O","role_mark_label":"Officer (Exec VP, General Counsel & Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec VP, General Counsel & Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":26.532533333333333,"price_display":"26.53","price_state":"stated","total_value":198994.0,"total_display":"198,994.00","total_whole":"198,994","shares_owned_after":46164.0,"shares_owned_after_display":"46,164","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-12-01","filed_date":"2010-12-03","scope":"insider","n_lines":2},{"id":5638039,"accession":"0001209191-09-055049","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-055049","line_url":"/filing/0001209191-09-055049#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352455","owner_name":"Wasman Jane","owner_display_name":"Wasman Jane","owner_url":"/insider/0001352455","role":"Officer (Exec VP, General Counsel & Sec)","role_mark":"O","role_mark_label":"Officer (Exec VP, General Counsel & Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec VP, General Counsel & Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":24.5013,"price_display":"24.50","price_state":"stated","total_value":122506.5,"total_display":"122,506.50","total_whole":"122,507","shares_owned_after":33664.0,"shares_owned_after_display":"33,664","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-01","filed_date":"2009-12-02","scope":"insider"},{"id":3778059,"accession":"0001209191-08-063863","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-063863","line_url":"/filing/0001209191-08-063863#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352455","owner_name":"Wasman Jane","owner_display_name":"Wasman Jane","owner_url":"/insider/0001352455","role":"Officer (Exec VP, General Counsel & Sec)","role_mark":"O","role_mark_label":"Officer (Exec VP, General Counsel & Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec VP, General Counsel & Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":15.98,"price_display":"15.98","price_state":"stated","total_value":39950.0,"total_display":"39,950.00","total_whole":"39,950","shares_owned_after":23664.0,"shares_owned_after_display":"23,664","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-12-01","filed_date":"2008-12-03","scope":"insider"},{"id":3514245,"accession":"0001179110-08-012127","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001179110-08-012127","line_url":"/filing/0001179110-08-012127","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352455","owner_name":"Wasman Jane","owner_display_name":"Wasman Jane","owner_url":"/insider/0001352455","role":"Officer (Exec VP, General Counsel & Sec)","role_mark":"O","role_mark_label":"Officer (Exec VP, General Counsel & Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec VP, General Counsel & Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":31.548571428571428,"price_display":"31.55","price_state":"stated","total_value":110420.0,"total_display":"110,420.00","total_whole":"110,420","shares_owned_after":27964.0,"shares_owned_after_display":"27,964","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-11","filed_date":"2008-06-13","scope":"insider","n_lines":9},{"id":3691321,"accession":"0001179110-08-009433","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001179110-08-009433","line_url":"/filing/0001179110-08-009433","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352455","owner_name":"Wasman Jane","owner_display_name":"Wasman Jane","owner_url":"/insider/0001352455","role":"Officer (Exec VP, General Counsel & Sec)","role_mark":"O","role_mark_label":"Officer (Exec VP, General Counsel & Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec VP, General Counsel & Sec","security_title":"Restricted Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2425.0,"shares_display":"2,425","price_per_share":19.10979381443299,"price_display":"19.11","price_state":"stated","total_value":46341.25,"total_display":"46,341.25","total_whole":"46,341","shares_owned_after":26664.0,"shares_owned_after_display":"26,664","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-05-12","filed_date":"2008-05-12","scope":"insider","n_lines":6},{"id":3934764,"accession":"0001179110-08-003053","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001179110-08-003053","line_url":"/filing/0001179110-08-003053#line-6","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352455","owner_name":"Wasman Jane","owner_display_name":"Wasman Jane","owner_url":"/insider/0001352455","role":"Officer (Exec VP, General Counsel & Sec)","role_mark":"O","role_mark_label":"Officer (Exec VP, General Counsel & Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec VP, General Counsel & Sec","security_title":"Restricted Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1283.0,"shares_display":"1,283","price_per_share":23.0,"price_display":"23.00","price_state":"stated","total_value":29509.0,"total_display":"29,509.00","total_whole":"29,509","shares_owned_after":14014.0,"shares_owned_after_display":"14,014","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-11","filed_date":"2008-02-12","scope":"insider"},{"id":3934762,"accession":"0001179110-08-003053","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-08-003053","line_url":"/filing/0001179110-08-003053#line-5","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352455","owner_name":"Wasman Jane","owner_display_name":"Wasman Jane","owner_url":"/insider/0001352455","role":"Officer (Exec VP, General Counsel & Sec)","role_mark":"O","role_mark_label":"Officer (Exec VP, General Counsel & Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec VP, General Counsel & Sec","security_title":"Restricted Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":23.04,"price_display":"23.04","price_state":"stated","total_value":11520.0,"total_display":"11,520.00","total_whole":"11,520","shares_owned_after":15314.0,"shares_owned_after_display":"15,314","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-11","filed_date":"2008-02-12","scope":"insider"},{"id":3934760,"accession":"0001179110-08-003053","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-08-003053","line_url":"/filing/0001179110-08-003053#line-4","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352455","owner_name":"Wasman Jane","owner_display_name":"Wasman Jane","owner_url":"/insider/0001352455","role":"Officer (Exec VP, General Counsel & Sec)","role_mark":"O","role_mark_label":"Officer (Exec VP, General Counsel & Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec VP, General Counsel & Sec","security_title":"Restricted Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":410.0,"shares_display":"410","price_per_share":22.9,"price_display":"22.90","price_state":"stated","total_value":9389.0,"total_display":"9,389.00","total_whole":"9,389","shares_owned_after":13589.0,"shares_owned_after_display":"13,589","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-11","filed_date":"2008-02-12","scope":"insider"}],"collapsed":true,"next_cursor":"2008-02-11|3934760","ledger_fault":false,"count":{"value":212,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":211,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":212},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001390478","name":"SELLAS Life Sciences Group, Inc.","url":"/issuer/0001390478","role":"Director","n_filings":1,"first_seen":"2025-06-02","last_seen":"2025-06-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001008848","name":"ACORDA THERAPEUTICS INC","url":"/issuer/0001008848","role":"Officer (President, Intl and GC)","n_filings":42,"first_seen":"2006-11-08","last_seen":"2019-12-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001352455","retrieved_at":"2026-08-26T13:38:25+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}